Salem Neuroserve Profile
Key Indicators
- Authorised Capital ₹ 2.45 M
- Paid Up Capital ₹ 2.45 M
- Company Age 24 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.66 Cr
- Satisfied Charges ₹ 5.63 M
- Revenue Growth 16.93%
- Profit Growth -107.48%
- Ebitda -33.48%
- Net Worth -0.49%
- Total Assets -12.85%
About Salem Neuroserve
Salem Neuroserve Private Limited (SNPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 November 2000 and has a history of 24 years and three months. Its registered office is in Salem, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.45 M and a paid-up capital of Rs 2.45 M.
The company currently has active open charges totaling ₹4.66 Cr. The company has closed loans amounting to ₹5.63 M, as per Ministry of Corporate Affairs (MCA) records.
Chellapandiyan Eswaradass, Singaram Sobanadevi, Gurunathan Umamaheswari, and One other member serve as directors at the Company.
Company Details
- Location
Salem, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85110TZ2000PTC009545
- Company No.
009545
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Nov 2000
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Who are the key members and board of directors at Salem Neuroserve?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Jayaraman Nandakumar ![]() | Managing Director | 01-Sep-2006 | Current |
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Singaram Sobanadevi ![]() | Whole-Time Director | 13-Nov-2000 | Current |
Chellapandiyan Eswaradass ![]() | Whole-Time Director | 13-Nov-2000 | Current |
Gurunathan Umamaheswari ![]() | Whole-Time Director | 13-Nov-2000 | Current |
Financial Performance of Salem Neuroserve.
Salem Neuroserve Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 16.93% increase. The company also saw a substantial fall in profitability, with a 107.48% decrease in profit. The company's net worth dipped by a decrease of 0.49%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Salem Neuroserve?
In 2020, Salem Neuroserve had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹46.61 M
₹5.63 M
Charges Breakdown by Lending Institutions
- Others : 4.16 Cr
- Icici Bank Ltd. : 0.50 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
12 Sep 2022 | Others | ₹6.27 M | Open |
25 Jan 2018 | Others | ₹3.53 Cr | Open |
30 Jun 2003 | Icici Bank Ltd. | ₹5.03 M | Open |
28 Mar 2005 | Icici Bank Ltd. | ₹5.63 M | Satisfied |
How Many Employees Work at Salem Neuroserve?
Unlock and access historical data on people associated with Salem Neuroserve, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Salem Neuroserve, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Salem Neuroserve's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.